Direct-to-Consumer Cardiac Screening and Suspect Risk Evaluation

Direct-to-consumer (DTC) genetic testing has generated much concern due to nonstandardized products, unproven utility, and potential harm from testing results.¹ Recommendations indicate that genetic testing should be US Food and Drug Administration (FDA)–approved, supported by predictive value and outcomes research, and offered only through qualified health care professionals.¹